These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
394 related items for PubMed ID: 11342997
21. Treatment of severe intermittent claudication with pentoxifylline: a 40-week, controlled, randomized trial. Cesarone MR, Belcaro G, Nicolaides AN, Griffin M, De Sanctis MT, Incandela L, Geroulakos G, Ramaswami G, Cazaubon M, Barsotti A, Vasdekis S, Bavera P, Ippolito E. Angiology; 2002; 53 Suppl 1():S1-5. PubMed ID: 11865828 [Abstract] [Full Text] [Related]
22. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication. Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attinà T, Dell'Arte S, Sarnataro F. Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509 [Abstract] [Full Text] [Related]
23. Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data. De Backer T, Vander Stichele R, Lehert P, Van Bortel L. BMJ; 2009 Mar 10; 338():b603. PubMed ID: 19276131 [Abstract] [Full Text] [Related]
24. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial. Messa GL, Gelso E. Drugs Exp Clin Res; 2002 Mar 10; 28(1):37-48. PubMed ID: 12073766 [Abstract] [Full Text] [Related]
29. Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication. Stevens JW, Simpson E, Harnan S, Squires H, Meng Y, Thomas S, Michaels J, Stansby G. Br J Surg; 2012 Dec 12; 99(12):1630-8. PubMed ID: 23034699 [Abstract] [Full Text] [Related]
30. Double-blind, controlled, multicenter study of indobufen versus placebo in patients with intermittent claudication. Tönnesen KH, Albuquerque P, Baitsch G, Gomez Alonso A, Ibanez F, Kester RC, Leveson S, Poredos P. Int Angiol; 1993 Dec 12; 12(4):371-7. PubMed ID: 8207316 [Abstract] [Full Text] [Related]
31. [European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication]. Laurora G, Corsi M, Bucci M, Cesarone MR, Belcaro G, Dugall M. Minerva Cardioangiol; 1998 Oct 12; 46(10 Suppl 1):21-9. PubMed ID: 10658441 [Abstract] [Full Text] [Related]
37. A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease. Squires H, Simpson E, Meng Y, Harnan S, Stevens J, Wong R, Thomas S, Michaels J, Stansby G. Health Technol Assess; 2011 Dec 23; 15(40):1-210. PubMed ID: 22142554 [Abstract] [Full Text] [Related]
38. [Double-blind randomized comparative study of nicergoline naftidrofuryl on the quality of life in chronic obliterative arteriopathy of lower limbs with intermittent claudication]. Meilhac B, Montestruc F, Aubin F, Djian F, Rouffy J. Therapie; 1997 Dec 23; 52(3):179-86. PubMed ID: 9366101 [Abstract] [Full Text] [Related]